Article info

Download PDFPDF
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)

Authors

  • Kin Seng Liem Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Scott Fung Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • David K Wong Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Colina Yim Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Seham Noureldin Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Jiayun Chen Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Jordan J Feld Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada Sandra Rotman Centre for Global Health, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Bettina E Hansen Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Harry L A Janssen Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Harry L A Janssen, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON M5T 2S8, Canada; harry.janssen{at}uhn.ca
View Full Text

Citation

Liem KS, Fung S, Wong DK, et al
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)

Publication history

  • Received April 26, 2019
  • Revised August 8, 2019
  • Accepted August 13, 2019
  • First published August 28, 2019.
Online issue publication 
November 07, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.